France's Carmat, a company that is building an entirely artificial human heart, is planning an initial public offering on the Alternext market of NYSE-Euronext Paris in June. The company, co-founded by renowned French heart surgeon Alain Carpentier, is leveraging the aerospace industry's expertise in modeling, stress testing, miniaturization and design for severe environments as well as the latest advances in software, medicine, biology and materials science. Click to read the story and see the video. Read more
Informilo is a news site that covers entrepreneurship and innovation in every part of the pipeline – from the smallest start-up with the best idea to big companies that embrace creative disruption. The aim is to help start-ups and venture capitalists benchmark the global competition and connect with big corporates. Founded by veteran journalist Jennifer L. Schenker, Informilo vows to adhere to the highest standards of editorial integrity.